For premenopausal women with ER-positive early breast cancer, even if chemotherapy or tamoxifen are given, OFS significantly reduces the 15-year risk of recurrence and death.
Plasma TP53 as an indicator of poor survival in neoadjuvant-treated triple negative breast cancer: A prospective study and meta-analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
Introduction Evidence-based parenting programmes are widely used to prevent violence against children and improve parenting ...